Last $46.39 USD
Change Today 0.00 / 0.00%
Volume 0.0
SNY On Other Exchanges
Symbol
Exchange
EN Paris
EN Paris
New York
OTC US
BrsaItaliana
Mexico
Frankfurt
Frankfurt
NASDAQ GM
As of 8:04 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for sanofi-adr (SNY)

Year over year, Sanofi has seen revenues fall from €34.9B EUR to €33.0B EUR. This along with an increase in the cost of goods sold expense has led to a reduction in the bottom line from €4.9B EUR to €3.7B EUR.
View Income Statement In U.S. Dollar
Currency in
Millions of Euros
As of:Dec 31
2010
Restated
EUR
Dec 31
2011
Restated
EUR
Dec 31
2012
Restated
EUR
Dec 31
2013
EUR
4 Year
Trend
Revenues32,367.033,389.034,947.032,951.0
Other Revenues1,669.01,669.01,010.0355.0
TOTAL REVENUES34,036.035,058.035,957.033,306.0
Cost of Goods Sold9,256.010,389.011,075.010,990.0
GROSS PROFIT24,780.024,669.024,882.022,316.0
Selling General & Admin Expenses, Total8,149.08,508.08,929.08,602.0
R&D Expenses4,547.04,788.04,905.04,770.0
Depreciation & Amortization, Total3,529.03,314.03,291.02,914.0
Other Operating Expenses-80.0403.0-414.0-163.0
OTHER OPERATING EXPENSES, TOTAL16,145.017,013.016,711.016,123.0
OPERATING INCOME8,635.07,656.08,171.06,193.0
Interest Expense-385.0-425.0-417.0-366.0
Interest and Investment Income61.0100.068.049.0
NET INTEREST EXPENSE-324.0-325.0-349.0-317.0
Income (Loss) on Equity Investments978.01,070.0393.035.0
Currency Exchange Gains (Loss)-161.05.0-58.0-59.0
Other Non-Operating Income (Expenses)-18.0-256.0-299.0-233.0
EBT, EXCLUDING UNUSUAL ITEMS9,110.08,150.07,858.05,619.0
Merger & Restructuring Charges-1,526.0-1,855.0-1,164.0-300.0
Gain (Loss) on Sale of Investments---33.07.042.0
Gain (Loss) on Sale of Assets---18.0--165.0
Other Unusual Items, Total-433.083.0-534.0-888.0
Legal Settlements-----225.0--
Other Unusual Items--225.0-192.0499.0
EBT, INCLUDING UNUSUAL ITEMS7,151.06,327.06,167.04,638.0
Income Tax Expense1,430.0440.01,109.0763.0
Minority Interest in Earnings-254.0-241.0-169.0-158.0
Earnings from Continuing Operations5,721.05,887.05,058.03,875.0
NET INCOME5,467.05,646.04,889.03,717.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS5,467.05,646.04,889.03,717.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS5,467.05,646.04,889.03,717.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SNY:US $46.39 USD 0.00

SNY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $67.71 USD 0.00
Amgen Inc $170.17 USD 0.00
Bayer AG €115.50 EUR +1.49
Bristol-Myers Squibb Co $61.30 USD 0.00
Celgene Corp $117.18 USD 0.00
View Industry Companies
 

Industry Analysis

SNY

Industry Average

Valuation SNY Industry Range
Price/Earnings 23.7x
Price/Sales 2.9x
Price/Book 1.9x
Price/Cash Flow 14.5x
TEV/Sales 2.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANOFI-ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.